Gregg Sando
Gregg Sando is the founder and CEO of Cell Medica.
After a career in investment banking based both in London and New York, he completed his Immunology MSc degree at the medical school of Imperial College. Recognizing the significant progress taking place in the field of cellular immunotherapy, Gregg formed Cell Medica in cooperation with a smallgroup of the leading clinicians and immunologists who were pioneering this new mode of medical treatment. (B.A. Biochemistry, Harvard University; M.B.A. University of Chicago; MSc Immunology, Imperial College London).
After a career in investment banking based both in London and New York, he completed his Immunology MSc degree at the medical school of Imperial College. Recognizing the significant progress taking place in the field of cellular immunotherapy, Gregg formed Cell Medica in cooperation with a smallgroup of the leading clinicians and immunologists who were pioneering this new mode of medical treatment. (B.A. Biochemistry, Harvard University; M.B.A. University of Chicago; MSc Immunology, Imperial College London).
Country:
UK